JN

Jayshriben Nipam Shah

Active Director Director DIN 06949920
DIN 06949920 First appointment Sep 2014 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2014
Shareholding value •••• Premium profile

About Jayshriben Nipam Shah

Data last updated:

Jayshriben Nipam Shah is a Director at Safetec Pharma Private Limited (since 2014). The company operates in Trading. Safetec Pharma Private Limited reported revenue of ₹55 Lakh (FY 2020).

DIN 06949920
Primary Designation Director
Industry Trading
First Appointment 10 Sep 2014
Oldest Company Age 12 yrs
Largest company Safetec Pharma Private Limited · ₹55 Lakh (FY 2020)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Safetec Pharma Private Limited U24232GJ2014PTC080747
Director10 Sep 20142014₹55 Lakh (FY 2020)Active

Board colleagues of Jayshriben Nipam Shah

NameDINCompanyDesignation
Chandubhai Maganlal Patel07820824Safetec Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Safetec Pharma Private Limited
Premium access

Shareholding and investment profile for Jayshriben Nipam Shah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jayshriben Nipam Shah

Jayshriben Nipam Shah currently holds 1 directorship: Safetec Pharma Private Limited (Director, since 10 Sep 2014, revenue ₹55 Lakh (FY 2020)).

Jayshriben Nipam Shah was first appointed on 10 Sep 2014 as Director at Safetec Pharma Private Limited.

The current boards of Jayshriben Nipam Shah's companies include Chandubhai Maganlal Patel (Safetec Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available